Skip to main content

Table 5 Association between the NT-proBNP and the risk of carotid artery plaques according to glucose regulation state

From: Relationship between the circulating N-terminal pro B-type natriuretic peptide and the risk of carotid artery plaque in different glucose metabolic states in patients with coronary heart disease: a CSCD-TCM plus study in China

Variables

Carotid artery plaques

OR (95% CI)a

P-value

OR (95% CI)b

P-value

OR (95% CI)c

P-value

Normal glucose regulation

 Continuous

(per 1 SD increase)

2.99(1.91–4.68)

 < 0.001

2.98(2.29–3.87)

 < 0.001

2.50(1.17–5.39)

0.018

 < 56

Reference

 

Reference

 

Reference

 

 [56–480]

1.39(1.07–1.79)

0.012

1.00(0.75–1.32)

0.971

0.87(0.61–1.23)

0.437

 > 480

2.45(1.83–3.29)

 < 0.001

1.43(1.03–1.97)

0.031

1.38(0.88–2.15)

0.161

 Ptrend

 < 0.001

 

0.015

 

0.002

 

Prediabetes

 Continuous

(per 1 SD increase)

1.25(0.98–1.60)

0.070

1.02(1.83–1.25)

0.875

1.14(0.80–1.62)

0.467

 < 56

Reference

 

Reference

 

Reference

 

 [56–480]

1.85(1.34–2.57)

 < 0.001

1.26(0.88–1.79)

0.205

1.27(0.83–1.95)

0.275

 > 480

2.71(1.90–3.85)

 < 0.001

1.48(1.10–2.20)

0.045

1.94(1.10–3.43)

0.023

 Ptrend

 < 0.001

 

0.089

 

0.003

 

Diabetes

 Continuous

(per 1 SD increase)

1.63(1.13–2.35)

0.009

1.40(0.99–1.98)

0.057

1.32(0.81–2.14)

0.266

 < 56

Reference

 

Reference

 

Reference

 

 [56–480]

1.551(1.14–2.12)

0.005

1.16(0.84–1.60)

0.376

1.07(0.72–1.58)

0.743

 > 480

2.34(1.68–3.25)

 < 0.001

1.69(1.20–2.39)

0.003

1.85(1.13–3.01)

0.014

 Ptrend

 < 0.001

 

0.003

 

0.010

 
  1. aModel 1: unadjusted
  2. bModel 2: adjusted for age, sex
  3. cModel 3: adjusted for age, sex, smoking, drinking, hypertension, hyperlipidemia, LVEF, proteinuria, previous MI, PCI or CABG, use of antihypertensives, and use of antilipidemic
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840